Rotzinger PharmaPack is launching a new filling and capping platform for over-the-counter (OTC) products such as non-aseptic pharmaceuticals as well as solid and liquid products from the cosmetics, personal care, and nutraceutical industries.
SGD Pharma, a provider of pharmaceutical glass packaging, has announced an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial S.r.l, a producer of Tubular Vials and Ampoules headquartered in Italy.
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, has announced that it has been selected by Calluna Pharma to support its study.
Tasso, a company in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics.
Aptamer Group, a developer of next-generation synthetic binders delivering innovation to the life science industry, has announced the launch of its biomarker discovery service.
Cartherics with lead programs in ovarian cancer and endometriosis, has announced the granting of a patent for ‘Method for Providing Immune Cells with Enhanced Function’ by the Chinese Patent Office.
Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships.
Bio-Rad Laboratories, a specialist in life science research and clinical diagnostics products, has announced the introduction of a new range of StarBright Dyes, designed to provide greater choice for spectral flow cytometry in immunology research.
Scenic Biotech, a pioneer in modifier therapies for severe diseases, has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic's Cell-Seq platform for discovering novel targets for RNAi therapeutics.
Er-Kim, an international pharma company specialising in the commercialisation of novel therapies, has announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central & Eastern Europe (CEE) and Türkiye.
ITF Therapeutics, the U.S. affiliate of Italfarmaco, has announced publication of positive long-term safety and efficacy data for givinostat as a treatment for Duchenne muscular dystrophy (DMD).
